secwatch / observer

8-K filed June 3, 2026, 7:25 AM ET CIK 0001567892

regulatory confidence high sentiment neutral materiality 0.10

Keenova shareholders elect all 9 director nominees, approve all proposals at annual meeting

Keenova Therapeutics plc

All 9 director nominees elected to hold office until 2027 AGM; average ~25.2M votes 'For' per nominee.
PricewaterhouseCoopers LLP re-appointed as independent auditor with 25.6M 'For' votes.
Say-on-pay approved (25.0M 'For' vs 0.3M 'Against'); frequency set to 1 year.
Special resolutions passed: capital reduction (25.3M 'For') and articles of association amendment (25.5M 'For').

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Keenova Therapeutics plc shareholders approved Election of directors to hold office until the 2027 Annual General Meeting at the 2026-06-02 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-02

Exact text from the filing

FOR AGAINST ABSTAIN BROKER NON-VOTES Paul M. Bisaro 25,282,713 8,884 191,295 310,829

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the frequency of future advisory non-binding votes to approve the Company's executive compensation at the 2026-06-02 meeting.

Proposal: say on pay frequency
Outcome: passed
Meeting: 2026-06-02

Exact text from the filing

1 YEAR 2 YEARS 3 YEARS ABSTAIN BROKER NON-VOTES 25,117,919 172,952 726 191,295 310,829

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the re-appointment of PricewaterhouseCoopers LLP as independent auditors and to authorize the Audit Committee to set the auditors’ remuneration at the 2026-06-02 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-02

Exact text from the filing

FOR AGAINST ABSTAIN BROKER NON-VOTES 25,602,426 0 191,295 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the Company's executive compensation at the 2026-06-02 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-02

Exact text from the filing

FOR AGAINST ABSTAIN BROKER NON-VOTES 24,965,301 326,296 191,295 310,829

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Keenova Therapeutics plc shareholders approved Approve the reduction of Company capital (Special Resolution) at the 2026-06-02 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2026-06-02

Exact text from the filing

FOR AGAINST ABSTAIN BROKER NON-VOTES 25,256,218 35,379 191,295 310,829

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Keenova Therapeutics plc shareholders approved Approve an amendment to the Company's articles of association (Special Resolution) at the 2026-06-02 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2026-06-02

Exact text from the filing

FOR AGAINST ABSTAIN BROKER NON-VOTES 25,476,547 6,345 0 310,829

View on SEC.gov

1586 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Source: SEC EDGAR

accession 0001104659-26-069792

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.